IP Library › Granted Patent US 12,292,360
Granted Patent B2
US 12,292,360 · App. 18/384,299 · Granted May 6, 2025

Preliminary diagnoses of cut tissue sections

Inventors: Partha P. Mitra (New York, NY); Charles R. Cantor (Del Mar, CA); Baris Yagci (Montclair, NY); Steven Smith (Hawthorne, NY)
G01N1/06G01N1/312G02B21/06G02B21/26G02B21/365G06T7/0012G06T2207/10056G06T2207/30024
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,292,360
App. No.
18/384,299
Granted
May 6, 2025
Kind
B2
Abstract

A system for optical interrogation of tissue samples, the system including: a microtome configured to section one or more tissue sections from a tissue block, the one or more tissue sections including one or more tissue samples; a transfer medium configured to gather the one or more tissue sections and to transfer the one or more tissue sections to one or more slides; and an optical interrogation system including an illumination system configured to illuminate the one or more tissue sections and an imaging system configured to perform an imaging analysis on the one or more tissue sections illuminated with the illumination system.

Claims (56)

1. A system for optical interrogation of tissue samples, the system comprising:

a microtome configured to section one or more tissue sections from a tissue block, the one or more tissue sections comprising one or more tissue samples;

an illumination system configured to illuminate the one or more tissue sections to optically stain the one or more tissue sections;

an imaging system configured to obtain imaging data on the one or more tissue sections illuminated with the illumination system; and

a processor being programmed to;

perform an imaging analysis of the imaging data to determine a presence or an absence of a disease in the one or more tissue sections illuminated with the illumination system; and

instruct the microtome to section one or more additional tissue sections for staining and imaging from the tissue block if there is a presence of the disease in the one or more tissue sections.

2. The system of claim 1 , wherein the illumination system is configured to illuminate the one or more tissue sections with structured light.

3. The system of claim 1 , wherein the imaging system is configured to obtain the imaging data with light microscopic resolution.

4. The system of claim 1 , wherein the imaging system comprises a microscopic scanner.

5. The system of claim 1 , wherein the imaging analysis to determine the presence or the absence of the disease is based on intrinsic properties of the one or more tissue sections.

6. A system for optical interrogation of tissue samples, the system comprising:

a microtome configured to section one or more tissue sections from a tissue block, the one or more tissue sections comprising one or more tissue samples;

an optical interrogation system comprising an illumination system configured to illuminate the one or more tissue sections to optically stain the one or more tissue sections and an imaging system configured to obtain imaging data indicative of intrinsic properties of the one or more tissue sections illuminated with the illumination system;

and

a processor in communication with the optical interrogation system, the processor being programmed to:

receive the imaging data from the optical interrogation system and to determine a presence or an absence of a disease in the one or more tissue sections; and

instruct the microtome to section one or more additional tissue sections for staining and imaging from the tissue block if there is a presence of the disease in the one or more tissue sections.

7. The system of claim 6 , wherein the processor is programmed to perform an analysis of the imaging data to determine a presence or an absence of a quality control issue in the one or more tissue samples of the one or more tissue sections.

8. The system of claim 6 further comprising a transfer medium configured to gather the one or more tissue sections and to transfer the one or more tissue sections to one or more slides.

9. The system of claim 6 , wherein the processor is configured to determine the presence or the absence of the disease in the one or more tissue sections by identifying a presence or an absence of one or more biomarkers indicative of the disease.

10. The system of claim 6 , wherein the processor is programmed to perform a diagnostic algorithm to generate a diagnostic value for the one or more tissue samples.

11. The system of claim 10 , wherein the diagnostic value is indicative of the presence or the absence of the disease.

12. The system of claim 11 , wherein the processor is programmed to instruct the microtome to section the one or more additional tissue sections if the diagnostic value is indicative of the presence of the disease.

13. The system of claim 6 , wherein the processor is configured to identify from the imaging data one or more biomarkers indicative of the disease in the one or more tissue samples and assign a diagnostic value for the one or more tissue samples based on the one or more biomarkers.

14. The system of claim 6 , wherein the illumination system is configured to illuminate the one or more tissue sections with structured light.

15. The system of claim 6 , wherein the imaging system is configured to obtain the imaging data with light microscopic resolution.

16. The system of claim 6 , wherein the imaging data comprises one or more images of the one or more tissue sections.

17. The system of claim 6 , wherein the processor is configured to present to a human user the imaging data as one or more images of the one or more tissue sections.

18. A method for optical interrogation of tissue samples, the method comprising:

sectioning, using a microtome one or more tissue sections from a tissue block, one or more tissue sections comprising one or more tissue samples;

illuminating, by an illumination system, the one or more tissue sections to optically stain the one or more tissue sections;

performing, by an imaging system, an imaging analysis to collect imaging data on the one or more tissue sections illuminated by the illumination system;

determining, by a processor and based on the imaging data, a presence or an absence of a disease in the one or more tissue sections; and

sectioning, by the microtome, one or more additional tissue sections for staining and imaging from the tissue block if there is a presence of the disease in the one or more tissue sections.

19. The method of claim 18 further comprising presenting the imaging data to one or more users as one or more images of the one or more tissue sections.

20. The method of claim 18 further comprising presenting to a human user one or more images of the one or more tissue samples after the one or more tissue samples is stained.

21. The method of claim 18 further comprising determining, by the processor and based on the imaging data, a presence or an absence of a quality control issue in the one or more tissue samples of the one or more tissue sections.

22. The method of claim 18 further comprising:

performing, by the processor, a diagnostic algorithm to generate a diagnostic value for the one or more tissue samples indicative of the presence or the absence of the disease in the one or more tissue samples; and

presenting the diagnostic value to a human user together with one or more images of the one or more tissue sections.

23. The method of claim 18 further comprising performing, by the processor, a diagnostic algorithm to generate a diagnostic value for the one or more tissue samples indicative of the presence or the absence of the disease.

24. A method for optical interrogation of tissue samples, the method comprising:

sectioning, using a microtome one or more tissue sections from a tissue block, one or more tissue sections comprising one or more tissue samples;

illuminating, by an illumination system, the one or more tissue sections to optically stain the one or more tissue sections;

obtaining, by an imaging system, imaging data of the one or more tissue sections to collect imaging data on the one or more tissue sections illuminated by the illumination system;

presenting the imaging data to a human user for determining a presence or an absence of a disease in the one or more tissue sections; and

sectioning, using the microtome, one or more additional tissue sections for staining and imaging from the tissue block if there is a presence of the disease in the one or more tissue sections.

25. A system for optical interrogation of tissue samples, the system comprising:

a microtome configured to section one or more tissue sections from a tissue block, the one or more tissue sections comprising one or more tissue samples;

an illumination system configured to illuminate the one or more tissue sections to optically stain the one or more tissue sections;

an imaging system configured to obtain imaging data on the one or more tissue sections illuminated with the illumination system; and

a processor being programmed to:

receive the imaging data;

present the imaging data to a human user for determining a presence or an absence of a disease in the one or more tissue sections; and

cause the microtome to section one or more additional tissue sections for staining and imaging from the tissue block if there is a presence of the disease in the one or more tissue sections.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2024
From: MITRA, PARTHA P.; CANTOR, CHARLES R.; YAGCI, BARIS; SMITH, STEVEN
To: CLARAPATH, INC.
Reel/Frame 066457/0750 →
Continuity (3)
Continuation 17451987 · Oct 22, 2021
Provisional Application 63104907 · Oct 23, 2020
Related Publication 20240167917A1 · May 23, 2024
References Cited (118)
US 4511224A · Sitte et al. · 1985 [cited by applicant]
US 5746855A · Bolles · 1998 [cited by applicant]
US 6387653B1 · Voneiff et al. · 2002 [cited by applicant]
US 6568307B1 · Günther · 2003 [cited by applicant]
US 7374907B1 · Voneiff et al. · 2008 [cited by applicant]
US 8074547B2 · Ito et al. · 2011 [cited by applicant]
US 8687858B2 · Walter et al. · 2014 [cited by applicant]
US 9032854B2 · Yang et al. · 2015 [cited by applicant]
US 9164014B2 · Ito · 2015 [cited by applicant]
US 9279749B2 · Donovan et al. · 2016 [cited by applicant]
US 9354147B2 · Lefebvre · 2016 [cited by applicant]
US 9933339B2 · Briggman · 2018 [cited by applicant]
US 10228311B2 · Stephens et al. · 2019 [cited by applicant]
US 10473557B2 · Mitra et al. · 2019 [cited by applicant]
US 10571368B2 · Zhang et al. · 2020 [cited by applicant]
US 10724929B2 · Zhang et al. · 2020 [cited by applicant]
US 11169056B2 · Mitra et al. · 2021 [cited by applicant]
US 11435268B2 · Mitra et al. · 2022 [cited by applicant]
US 11467071B2 · Mitra et al. · 2022 [cited by applicant]
US 11506577B2 · Zhang et al. · 2022 [cited by applicant]
US 11609162B2 · Mitra et al. · 2023 [cited by applicant]
US 11630035B2 · Mitra et al. · 2023 [cited by applicant]
US 11821826B2 · Mitra et al. · 2023 [cited by applicant]
US 11874208B2 · Mitra et al. · 2024 [cited by applicant]
US 11898948B2 · Mitra et al. · 2024 [cited by applicant]
US 11959835B2 · Mitra · 2024 [cited by examiner]
US 20030022271A1 · Voneiff et al. · 2003 [cited by applicant]
US 20030120633A1 · Torre-Bueno · 2003 [cited by applicant]
US 20050235542A1 · Metzner et al. · 2005 [cited by applicant]
US 20060086221A1 · Kong et al. · 2006 [cited by applicant]
US 20070039435A1 · Kokubo · 2007 [cited by applicant]
US 20070141711A1 · Stephens et al. · 2007 [cited by applicant]
US 20070180965A1 · Ito · 2007 [cited by examiner]
US 20070199418A1 · Ito · 2007 [cited by applicant]
US 20090110253A1 · Torre-Bueno · 2009 [cited by applicant]
US 20090214088A1 · Sorenson et al. · 2009 [cited by applicant]
US 20100021037A1 · Zahniser et al. · 2010 [cited by applicant]
US 20100093022A1 · Hayworth et al. · 2010 [cited by applicant]
US 20100118133A1 · Walter et al. · 2010 [cited by applicant]
US 20100279342A1 · Kijima et al. · 2010 [cited by applicant]
US 20110111435A1 · Dobson · 2011 [cited by examiner]
US 20110249109A1 · Fine · 2011 [cited by applicant]
US 20110303352A1 · Nakajima et al. · 2011 [cited by applicant]
US 20120149050A1 · Lapen et al. · 2012 [cited by applicant]
US 20130164781A1 · Lefebvre · 2013 [cited by applicant]
US 20140026683A1 · Hayworth et al. · 2014 [cited by applicant]
US 20140041500A1 · Isagawa et al. · 2014 [cited by applicant]
US 20140051158A1 · Nakajima et al. · 2014 [cited by applicant]
US 20140098376A1 · Hashimshony et al. · 2014 [cited by applicant]
US 20140137715A1 · Sneyders et al. · 2014 [cited by applicant]
US 20150013512A1 · Yang et al. · 2015 [cited by applicant]
US 20150017679A1 · Ito · 2015 [cited by applicant]
US 20150268141A1 · Miyatani · 2015 [cited by applicant]
US 20150293026A1 · Shin et al. · 2015 [cited by applicant]
US 20160063724A1 · Tunstall et al. · 2016 [cited by applicant]
US 20160091400A1 · Whited et al. · 2016 [cited by applicant]
US 20160139004A1 · Witte · 2016 [cited by applicant]
US 20160245833A1 · Lefebvre · 2016 [cited by applicant]
US 20170003309A1 · Mitra et al. · 2017 [cited by applicant]
US 20170067800A1 · Briggman · 2017 [cited by examiner]
US 20170161428A1 · Mitra · 2017 [cited by applicant]
US 20170205317A1 · Zhang et al. · 2017 [cited by applicant]
US 20170276574A1 · Webber et al. · 2017 [cited by applicant]
US 20170328818A1 · Zhang et al. · 2017 [cited by applicant]
US 20170372471A1 · Euren · 2017 [cited by applicant]
US 20180108163A1 · Remiszewski · 2018 [cited by applicant]
US 20180136089A1 · Bui et al. · 2018 [cited by applicant]
US 20190176194A1 · Chen et al. · 2019 [cited by applicant]
US 20190250071A1 · Hayworth et al. · 2019 [cited by applicant]
US 20190301980A1 · Anderson et al. · 2019 [cited by applicant]
US 20190355135A1 · Rhodes · 2019 [cited by applicant]
US 20190368982A1 · Schleifer et al. · 2019 [cited by applicant]
US 20200041387A1 · Rhodes et al. · 2020 [cited by applicant]
US 20200064232A1 · Mitra et al. · 2020 [cited by applicant]
US 20200160522A1 · Merlo et al. · 2020 [cited by applicant]
US 20200166434A1 · Zhang et al. · 2020 [cited by applicant]
US 20200388032A1 · Chiang et al. · 2020 [cited by applicant]
US 20210262905A1 · Mitra et al. · 2021 [cited by applicant]
US 20210262907A1 · Mitra et al. · 2021 [cited by applicant]
US 20210263055A1 · Mitra et al. · 2021 [cited by applicant]
US 20220034768A1 · Mitra et al. · 2022 [cited by applicant]
US 20220034769A1 · Mitra et al. · 2022 [cited by applicant]
US 20220042887A1 · Mitra et al. · 2022 [cited by applicant]
US 20220113228A1 · Mitra et al. · 2022 [cited by applicant]
US 20220128810A1 · Mitra et al. · 2022 [cited by applicant]
US 20220349788A1 · Mitra et al. · 2022 [cited by applicant]
US 20220364960A1 · Smith et al. · 2022 [cited by applicant]
US 20220404241A1 · Yagci et al. · 2022 [cited by applicant]
US 20230057075A1 · Zhang et al. · 2023 [cited by applicant]
US 20230126618A1 · Mitra et al. · 2023 [cited by applicant]
US 20230221222A1 · Mitra et al. · 2023 [cited by applicant]
US 20230228651A1 · Yagci et al. · 2023 [cited by applicant]
US 20230359010A1 · Chen · 2023 [cited by examiner]
US 20240288342A1 · Mitra et al. · 2024 [cited by applicant]
CN 212115045U · 2020 [cited by applicant]
DE 102011116555A1 · 2013 [cited by applicant]
DE 102017118304A1 · 2018 [cited by applicant]
EP 0111290A2 · 1984 [cited by applicant]
JP S6385426A · 1988 [cited by applicant]
JP 2000190291A · 2000 [cited by applicant]
JP 2001324423A · 2001 [cited by applicant]
JP 2004013435A · 2004 [cited by applicant]
JP 2007218616A · 2007 [cited by applicant]
JP 2012229993A · 2012 [cited by applicant]
JP 2012229995A · 2012 [cited by applicant]
WO 1997003827A1 · 1997 [cited by applicant]
WO 2010151761A2 · 2010 [cited by applicant]
WO 2012147730A1 · 2012 [cited by applicant]
WO 2015046518A1 · 2015 [cited by applicant]
WO 2015175525A1 · 2015 [cited by applicant]
WO 2019209743A1 · 2019 [cited by applicant]
WO 2021168457A1 · 2021 [cited by applicant]
WO 2022087443A1 · 2022 [cited by applicant]
WO 2022241261A1 · 2022 [cited by applicant]
WO 2022271732A1 · 2022 [cited by applicant]
WO 2023092156A1 · 2023 [cited by applicant]
WO 2023122620A2 · 2023 [cited by applicant]
International Search Report in PCT International Application No. PCT/US2022/056291 mailed Jan. 24, 2022. [cited by applicant]
Cited By (4)
US 12,498,298 US 12,650,366 US 12,699,027 US 12,699,028